Cargando…
JuBei Oral Liquid Induces Mitochondria-Mediated Apoptosis in NSCLC Cells
BACKGROUND: Although gefitinib brings about tremendous advances in the treatment of non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations, most of patients become incurable due to drug resistance. JuBei oral liquid (JB) has been widely used to treat pneumonia...
Autores principales: | Pan, Zhenzhen, Chen, Qiufang, Zheng, Xiulan, Wang, Kai, Duan, Yalei, Xiao, Kang, Jia, Zhirong, Ding, Xuansheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423349/ https://www.ncbi.nlm.nih.gov/pubmed/32821122 http://dx.doi.org/10.2147/OTT.S254464 |
Ejemplares similares
-
Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression
por: Pan, Zhenzhen, et al.
Publicado: (2022) -
SFI Enhances Therapeutic Efficiency of Gefitinib: An Insight into Reversal of Resistance to Targeted Therapy in Non-small Cell Lung Cancer Cells
por: Pan, Zhenzhen, et al.
Publicado: (2020) -
Claudin1 decrease induced by 1,25-dihydroxy-vitamin D3 potentiates gefitinib resistance therapy through inhibiting AKT activation-mediated cancer stem-like properties in NSCLC cells
por: Jia, Zhirong, et al.
Publicado: (2022) -
Wielki Wybuch ju
Publicado: (2008) -
Linking apoptosis to cancer metabolism: Another missing piece of JuNK
por: Papa, Salvatore, et al.
Publicado: (2016)